12:00 AM
 | 
Feb 05, 2007
 |  BC Week In Review  |  Clinical News  |  Regulatory

Gestiva regulatory update

FDA granted Orphan Drug designation for Gestiva to prevent preterm birth in women with a history of preterm...

Read the full 68 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >